Eintrag weiter verarbeiten
Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Pos...
Gespeichert in:
Veröffentlicht in: | Journal of clinical oncology 30(2012), 35, Seite 4323-4329 |
---|---|
Personen und Körperschaften: | , |
Titel: | Initial Molecular Response at 3 Months May Predict Both Response and Event-Free Survival at 24 Months in Imatinib-Resistant or -Intolerant Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Treated With Nilotinib/ Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop M. Kantarjian, Giovanni Martinelli, Jerald P. Radich, Giuseppe Saglio, Andreas Hochhaus, Timothy P. Hughes, and Martin C. Müller |
Format: | E-Book-Kapitel |
Sprache: | Englisch |
veröffentlicht: |
2012
|
Gesamtaufnahme: |
: Journal of clinical oncology, 30(2012), 35, Seite 4323-4329
, volume:30 |
Erscheint auch als: | Branford, Susan, Initial molecular response at 3 months may predict both response and event-free survival at 24 months in imatinib-resistant or -intolerant patients with philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with nilotinib, 2012 |
Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |